Costs of biomarker testing in advanced non-small cell lung cancer: a global study comparing next-generation sequencing and single-gene testing
Qualified researchers may request data from Amgen. Complete details are available at: http://www.amgen.com/datasharing.
| Autores: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2025 |
| País: | España |
| Recursos: | Consejo Superior de Investigaciones Científicas (CSIC) |
| Repositorio: | DIGITAL.CSIC. Repositorio Institucional del CSIC |
| OAI Identifier: | oai:digital.csic.es:10261/390683 |
| Acesso em linha: | http://hdl.handle.net/10261/390683 https://api.elsevier.com/content/abstract/scopus_id/86000636851 |
| Access Level: | acceso abierto |
| Palavra-chave: | NSCLC Cost comparison Next‐generation sequencing Precision medicine Predictive biomarker Single‐gene testing |
| Resumo: | Qualified researchers may request data from Amgen. Complete details are available at: http://www.amgen.com/datasharing. |
|---|